Distinctions in the molecular determinants of charged and neutral dihydropyridine block of L-type calcium channels
- PMID: 10336541
Distinctions in the molecular determinants of charged and neutral dihydropyridine block of L-type calcium channels
Abstract
We investigated block of the alpha1Cb subunit of L-type calcium channels by dihydropyridines (DHPs) in which a permanently charged or neutral head group was linked to the active DHP moiety by a spacer chain containing ten methylene (-CH2) groups. We compared the sensitivity of channel modulation by the charged (DHPch) and neutral (DHPn) forms to specific alpha1Cb mutations in domains IIIS5, IIIS6, and IVS6, which had previously been shown to reduce channel modulation by the neutral DHP (+)-isradipine. The effects of these mutations were studied on channel block recorded from polarized (-80 mV) and depolarized (-40 mV) holding potentials (HPs). We found that channel block by DHPn was markedly reduced at both HPs by each mutation studied. In contrast, channel block by DHPch was only modestly reduced by mutations in IIIS6 and IVS6 for block from either -40 mV or -80 mV. Replacement of IIIS5 Thr1061 by Tyr, which abolished block by DHPn in an HP-independent manner, had little effect on channel block by DHPch recorded from -40 mV. However, this mutation markedly reduced DHPch block of currents recorded from a -80 mV HP. Inhibition of current by DHPch was not markedly use-dependent, in contrast with block by verapamil, another charged calcium channel blocker. These results suggest that the presence of a permanently charged head group restricts the access of the attached DHP moiety to a subset of interaction residues on the alpha1C subunit in a voltage-dependent manner. Furthermore, these restricted interactions confer distinct functional properties upon the charged DHP molecules.
Similar articles
-
The IVS6 segment of the L-type calcium channel is critical for the action of dihydropyridines and phenylalkylamines.EMBO J. 1996 May 15;15(10):2365-70. EMBO J. 1996. PMID: 8665843 Free PMC article.
-
L-type calcium channels: asymmetrical intramembrane binding domain revealed by variable length, permanently charged 1,4-dihydropyridines.Mol Pharmacol. 1994 Oct;46(4):660-6. Mol Pharmacol. 1994. PMID: 7969044
-
Conserved Ca2+-antagonist-binding properties and putative folding structure of a recombinant high-affinity dihydropyridine-binding domain.Biochem J. 2000 May 1;347 Pt 3(Pt 3):829-36. Biochem J. 2000. PMID: 10769189 Free PMC article.
-
Voltage-dependent calcium channels.Gen Physiol Biophys. 2005 Jun;24 Suppl 1:1-78. Gen Physiol Biophys. 2005. PMID: 16096350 Review.
-
Molecular determinants of drug binding and action on L-type calcium channels.Annu Rev Pharmacol Toxicol. 1997;37:361-96. doi: 10.1146/annurev.pharmtox.37.1.361. Annu Rev Pharmacol Toxicol. 1997. PMID: 9131258 Review.
Cited by
-
Atherosclerosis-related molecular alteration of the human CaV1.2 calcium channel alpha1C subunit.Proc Natl Acad Sci U S A. 2006 Nov 7;103(45):17024-9. doi: 10.1073/pnas.0606539103. Epub 2006 Oct 27. Proc Natl Acad Sci U S A. 2006. PMID: 17071743 Free PMC article.
-
Molecular mechanisms of vasoselectivity of the 1,4-dihydropyridine lercanidipine.Br J Pharmacol. 2004 May;142(2):275-84. doi: 10.1038/sj.bjp.0705786. Br J Pharmacol. 2004. PMID: 15155536 Free PMC article.
-
Elucidation of molecular kinetic schemes from macroscopic traces using system identification.PLoS Comput Biol. 2017 Feb 13;13(2):e1005376. doi: 10.1371/journal.pcbi.1005376. eCollection 2017 Feb. PLoS Comput Biol. 2017. PMID: 28192423 Free PMC article.
-
Calcium Homeostasis, Transporters, and Blockers in Health and Diseases of the Cardiovascular System.Int J Mol Sci. 2023 May 15;24(10):8803. doi: 10.3390/ijms24108803. Int J Mol Sci. 2023. PMID: 37240147 Free PMC article. Review.
-
Distinct properties of amlodipine and nicardipine block of the voltage-dependent Ca2+ channels Cav1.2 and Cav2.1 and the mutant channels Cav1.2/dihydropyridine insensitive and Cav2.1/dihydropyridine sensitive.Eur J Pharmacol. 2011 Nov 16;670(1):105-13. doi: 10.1016/j.ejphar.2011.08.005. Epub 2011 Sep 2. Eur J Pharmacol. 2011. PMID: 21910984 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Research Materials
Miscellaneous